口服4-去甲氧基柔红霉素的抗肿瘤活性。 - Suppr

Suppr

超能文献

Antitumor activity of 4-demethoxydaunorubicin administered orally.

作者信息

Di Marco A, Casazza A M, Pratesi G

出版信息

Cancer Treat Rep. 1977 Aug;61(5):893-4.

PMID:890695

Abstract

摘要

相似文献

Antitumor activity of 4-demethoxydaunorubicin administered orally.口服4-去甲氧基柔红霉素的抗肿瘤活性。

Cancer Treat Rep. 1977 Aug;61(5):893-4.

Antileukemic activity of 4-demethoxydaunorubicin in mice.4-去甲氧基柔红霉素在小鼠体内的抗白血病活性。

Tumori. 1980 Oct 31;66(5):549-64. doi: 10.1177/030089168006600503.

Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.

Cancer Treat Rep. 1978 Jan;62(1):105-10.

[Antitumor activity of adriamycin].[阿霉素的抗肿瘤活性]

Jpn J Antibiot. 1972 Apr;25(2):65-71.

[Antitumor activities of orally administered 7-con-0-methylnogarol (TUT-7)].口服7-顺式-0-甲基诺加罗醇（TUT-7）的抗肿瘤活性

Gan To Kagaku Ryoho. 1990 Mar;17(3 Pt 1):353-8.

[Synthesis and antitumor properties of carminomycin 13-cyclohexylidenhydrazone].[洋红霉素13-环己叉腙的合成及其抗肿瘤特性]

Antibiotiki. 1983 Feb;28(2):95-9.

Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers.4-去甲氧基柔红霉素、4-去甲氧基-7,9-二表柔红霉素及其β异头物的合成与抗肿瘤活性

Cancer Treat Rep. 1976 Jul;60(7):829-34.

[Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice].阿霉素对小鼠白血病及各种腹水瘤的抗肿瘤活性

Antibiotiki. 1984 Nov;29(11):861-6.

Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.阿霉素和柔红霉素：免疫抑制后小鼠体内抗肿瘤活性及组织摄取的比较

Cancer Res. 1973 Aug;33(8):1837-44.

Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors.口服给予的聚合物偶联蛋白药物SMANCS对携带各种小鼠肿瘤的小鼠的抗肿瘤活性。

Anticancer Res. 1992 Nov-Dec;12(6B):2219-24.

引用本文的文献

Oral idarubicin. A review of its pharmacological properties and clinical efficacy in the treatment of haematological malignancies and advanced breast cancer.口服伊达比星。其药理学特性及治疗血液系统恶性肿瘤和晚期乳腺癌临床疗效的综述。

Drugs Aging. 1997 Jul;11(1):61-86. doi: 10.2165/00002512-199711010-00006.

Clinical pharmacokinetics of idarubicin.伊达比星的临床药代动力学。

Clin Pharmacokinet. 1993 Apr;24(4):275-88. doi: 10.2165/00003088-199324040-00002.

Oral idarubicin--an anthracycline derivative with unique properties.口服伊达比星——一种具有独特性质的蒽环类衍生物。

Ann Hematol. 1993 Jan;66(1):33-43. doi: 10.1007/BF01737687.

Potential role of oral anthracyclines in older patients with cancer.口服蒽环类药物在老年癌症患者中的潜在作用。

Drugs Aging. 1994 May;4(5):392-402. doi: 10.2165/00002512-199404050-00004.

Intravesical idarubicin--a phase-I study.

Urol Res. 1994;22(2):99-104. doi: 10.1007/BF00310999.

Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemia.伊达比星（4-去甲氧柔红霉素）治疗成人急性白血病的I期试验。

Invest New Drugs. 1984;2(4):375-9. doi: 10.1007/BF00171588.

Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses.4-去甲氧柔红霉素（伊达比星）单剂量口服的I期试验。

Invest New Drugs. 1984;2(3):281-6. doi: 10.1007/BF00175378.

Phase I study of 4-demethoxydaunorubicin.4-去甲氧基柔红霉素的I期研究。

Invest New Drugs. 1983;1(2):161-8. doi: 10.1007/BF00172075.

Intravenous and oral demethoxydaunorubicin (NSC 256-439) in the treatment of acute leukemia and lymphoma: a pilot study.

Blut. 1985 Jun;50(6):369-72. doi: 10.1007/BF00320931.

Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies.伊达比星（4-去甲氧基柔红霉素）。临床前和临床研究的初步概述。

Invest New Drugs. 1986;4(1):85-105. doi: 10.1007/BF00172021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验